Status:
UNKNOWN
The Reduction in Glucose Stimulated Insulin Secretion Induced by Cytokines May be Prevented by Copper Addition - Studies in Diabetic Patients
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Hyperglycemia
Diabetes
Eligibility:
All Genders
30-80 years
Phase:
NA
Brief Summary
In the CDs rat model, beta-cell dysfunction and pancreatic exocrine damage are triggered and prevented by altering dietary Cu content suggesting a chronic and acute role for Cu. These abnormalities be...
Eligibility Criteria
Inclusion
- diabetic subjects with BMI \< 33
- HbA1C \< 8
- plasma copper levels of \< 90 ul/dl
Exclusion
- patients with bad physical conditions
Key Trial Info
Start Date :
September 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00846144
Start Date
September 1 2009
End Date
December 1 2010
Last Update
February 18 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Diabetes Unit, Hadassah Medical Organization
Jerusalem, Israel, 91120